Blog
RSS FeedPosted by Michael Wonder on 22 Nov 2016
U.S. FDA grants fast track designation for the development of Oragenics’ AG013 for oral mucositis
21 November 2016 - Oragenics today announced that the U.S. FDA granted fast track designation to AG013, the Company’s lead ...
Posted by Michael Wonder on 22 Nov 2016
Genmab announces U.S. FDA approval of Darzalex (daratumumab) for relapsed multiple myeloma
21 November 2016 - Darzalex (daratumumab) approved by U.S. FDA in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone for ...
Posted by Michael Wonder on 21 Nov 2016
Regeneron CEO: A few ‘bad actors’ are raising drug prices for no reason
19 November 2016 - At an EY forum on Friday, the CEO of Regeneron Pharmaceuticals acknowledged that “really bad actors” ...
Posted by Michael Wonder on 21 Nov 2016
Amgen eyes spending caps to win payer nods on migraine prospect erenumab
21 November 2016 - Note to drugmakers negotiating with payers: it’s not the price tag that’s the problem, or at ...
Posted by Michael Wonder on 21 Nov 2016
Pfizer sues Texas health agency for releasing confidential pricing information
18 November 2016 - Pfizer has sued Texas' health agency, claiming it violated state and federal law by releasing the ...
Posted by Michael Wonder on 21 Nov 2016
GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD
21 November 2016 - GSK and Innoviva today announced the filing by GSK of a regulatory submission with the US ...
Posted by Michael Wonder on 19 Nov 2016
Spectrum Pharmaceuticals says FDA rejects its bladder cancer drug
18 November 2016 - Spectrum Pharmaceuticals said on Friday the U.S. FDA had rejected its bladder cancer treatment, apaziquone. ...
Posted by Michael Wonder on 18 Nov 2016
U.S. FDA grants fast track designation for the development of Eisai's BACE inhibitor E2609 for early Alzheimer's disease
18 November 2016 - Eisai announced today that the U.S. FDA has granted fast track designation for the development of the ...
Posted by Michael Wonder on 17 Nov 2016
FDA approves Intrarosa for postmenopausal women experiencing pain during sex
17 November 2016 - The U.S. FDA approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse ...
Posted by Michael Wonder on 17 Nov 2016
Centrexion Therapeutics announces fast track designation granted by FDA to CNTX-4975 for treatment of Morton’s neuroma
15 November 2016 - CNTX-4975 has potential to be the first non-surgical FDA-approved treatment for orphan disease, painful foot nerve ...
Posted by Michael Wonder on 16 Nov 2016
How drug price pressure helped sink Novo's insulin pill
16 November 2016 - Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk's bid to make an oral form of ...
Posted by Michael Wonder on 16 Nov 2016
How to make drug prices fair to U.S. consumers
16 November 2016 - Americans pay far more for branded prescription drugs than people in any other developed nation, exactly ...
Posted by Michael Wonder on 16 Nov 2016
Trump used to rail against drug prices. Now the industry's allies are helping shape his agenda
15 November 2016 - President-elect Donald Trump made the cost of prescription drugs a central part of his healthcare pitch while ...
Posted by Michael Wonder on 16 Nov 2016
AMA embraces value-based drug pricing
15 November 2016 - The US' largest physician organisation is supporting value-based pricing for medications. ...
Posted by Michael Wonder on 16 Nov 2016
Study shows promise for expensive cholesterol drugs, but they are still hard to obtain
15 November 2016 - If there is one thing decades of studies with tens of thousands of heart disease patients ...